| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Daniella Castanheira Bartholomeu | Q41905720 |
| João Luís Reis-Cunha | Q58873382 | ||
| P2093 | author name string | Mariana S Cardoso | |
| P2860 | cites work | The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease | Q22065799 |
| A Toll-like receptor recognizes bacterial DNA | Q24290668 | ||
| A 9,000-year record of Chagas' disease | Q24621555 | ||
| Unveiling the intracellular survival gene kit of trypanosomatid parasites | Q27003077 | ||
| Insufficient TLR activation contributes to the slow development of CD8+ T cell responses in Trypanosoma cruzi infection | Q39332973 | ||
| Trypanosoma cruzi calreticulin inhibits the complement lectin pathway activation by direct interaction with L-Ficolin | Q39479713 | ||
| LYT1 protein is required for efficient in vitro infection by Trypanosoma cruzi. | Q39520750 | ||
| Molecular mechanisms involved in the inactivation of the first component of human complement by Trypanosoma cruzi calreticulin | Q39545681 | ||
| The Trypanosoma cruzi enzyme TcGPXI is a glycosomal peroxidase and can be linked to trypanothione reduction by glutathione or tryparedoxin. | Q39594349 | ||
| TcGPXII, a glutathione-dependent Trypanosoma cruzi peroxidase with substrate specificity restricted to fatty acid and phospholipid hydroperoxides, is localized to the endoplasmic reticulum | Q39594356 | ||
| Distinct mitochondrial and cytosolic enzymes mediate trypanothione-dependent peroxide metabolism in Trypanosoma cruzi | Q39594361 | ||
| Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses. | Q39655557 | ||
| Trypanosoma cruzi calreticulin: a novel virulence factor that binds complement C1 on the parasite surface and promotes infectivity | Q39703575 | ||
| Heme controls ferroportin1 (FPN1) transcription involving Bach1, Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter | Q39736112 | ||
| Biology of Trypanosoma cruzi | Q39879813 | ||
| Recruitment and endo-lysosomal activation of TLR9 in dendritic cells infected with Trypanosoma cruzi. | Q39964182 | ||
| Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. | Q40157048 | ||
| Differential use of TLR2 and TLR9 in the regulation of immune responses during the infection with Trypanosoma cruzi | Q40280437 | ||
| Living dangerously: how Trypanosoma cruzi uses lysosomes to get inside host cells, and then escapes into the cytoplasm. | Q40479781 | ||
| Macrophage-derived peroxynitrite diffusion and toxicity to Trypanosoma cruzi | Q40492558 | ||
| TLR9 signals after translocating from the ER to CpG DNA in the lysosome | Q40600429 | ||
| Immediate/early response to Trypanosoma cruzi infection involves minimal modulation of host cell transcription | Q40773508 | ||
| Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite | Q40797228 | ||
| Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. | Q40901873 | ||
| Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses | Q41049640 | ||
| A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH. | Q41730283 | ||
| Immunological dominance of Trypanosoma cruzi tandem repeat proteins | Q42406598 | ||
| Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery | Q43309611 | ||
| Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance | Q43486494 | ||
| The ancient and divergent origins of the human pathogenic trypanosomes, Trypanosoma brucei and T. cruzi | Q43834978 | ||
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| Pathogen recognition and innate immunity | Q27861084 | ||
| Pattern recognition receptors and inflammation | Q27861115 | ||
| CD8+ T cells in Trypanosoma cruzi infection | Q28081766 | ||
| Shotgun sequencing analysis of Trypanosoma cruzi I Sylvio X10/1 and comparison with T. cruzi VI CL Brener | Q28477359 | ||
| The history of Chagas disease | Q28655492 | ||
| Membrane vesicles as conveyors of immune responses | Q29547765 | ||
| Superoxide radical and superoxide dismutases | Q29614204 | ||
| The biogenesis of lysosomes | Q29617860 | ||
| Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants | Q30652825 | ||
| CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes | Q33252349 | ||
| Proteomic analysis of metacyclic trypomastigotes undergoing Trypanosoma cruzi metacyclogenesis. | Q33303873 | ||
| The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination | Q33372349 | ||
| HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease | Q33375075 | ||
| Genomic organization and expression profile of the mucin-associated surface protein (masp) family of the human pathogen Trypanosoma cruzi | Q33425111 | ||
| Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells | Q33543089 | ||
| A partial cDNA clone of trypomastigote decay-accelerating factor (T-DAF), a developmentally regulated complement inhibitor of Trypanosoma cruzi, has genetic and functional similarities to the human complement inhibitor DAF. | Q33607295 | ||
| Specific humoral immunity versus polyclonal B cell activation in Trypanosoma cruzi infection of susceptible and resistant mice | Q33631293 | ||
| Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses | Q33652450 | ||
| Stable transfection of Trypanosoma cruzi epimastigotes with the trypomastigote-specific complement regulatory protein cDNA confers complement resistance | Q33754261 | ||
| Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection | Q33767207 | ||
| Lymphocyte polyclonal activation: a pitfall for vaccine design against infectious agents | Q33826635 | ||
| A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase | Q33912838 | ||
| Subdominant/cryptic CD8 T cell epitopes contribute to resistance against experimental infection with a human protozoan parasite. | Q33968196 | ||
| Analyses of 32 loci clarify phylogenetic relationships among Trypanosoma cruzi lineages and support a single hybridization prior to human contact | Q33988951 | ||
| Genomic analyses, gene expression and antigenic profile of the trans-sialidase superfamily of Trypanosoma cruzi reveal an undetected level of complexity. | Q34062280 | ||
| DNA and mRNA elements with complementary responses to hemin, antioxidant inducers, and iron control ferritin-L expression | Q34085026 | ||
| Role of host lysosomal associated membrane protein (LAMP) in Trypanosoma cruzi invasion and intracellular development | Q34108128 | ||
| A single enzyme catalyses formation of Trypanothione from glutathione and spermidine in Trypanosoma cruzi | Q34139347 | ||
| Trypanosoma cruzi expresses a plant-like ascorbate-dependent hemoperoxidase localized to the endoplasmic reticulum | Q34159631 | ||
| Perpetual expression of PAMPs necessary for optimal immune control and clearance of a persistent pathogen | Q34164082 | ||
| Parasite polyclonal activators: new targets for vaccination approaches? | Q34240147 | ||
| The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion | Q43898130 | ||
| Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi | Q44093805 | ||
| Maximum-likelihood divergence date estimates based on rRNA gene sequences suggest two scenarios of Trypanosoma cruzi intraspecific evolution | Q44386235 | ||
| Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils | Q44410424 | ||
| Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation | Q44522457 | ||
| Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. | Q44522735 | ||
| The classical activation pathway of the human complement system is specifically inhibited by calreticulin from Trypanosoma cruzi | Q44772790 | ||
| Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection | Q44832922 | ||
| Complement C2 receptor inhibitor trispanning confers an increased ability to resist complement-mediated lysis in Trypanosoma cruzi | Q46581413 | ||
| The Trypanosoma cruzi proteome. | Q46601686 | ||
| What has DNA sequencing revealed about the VSG expression sites of African trypanosomes? | Q46673837 | ||
| The Lipid Structure of the Glycosylphosphatidylinositol-anchored Mucin-like Sialic Acid Acceptors of Trypanosoma cruzi Changes during Parasite Differentiation from Epimastigotes to Infective Metacyclic Trypomastigote Forms | Q47630684 | ||
| Mortality due to Chagas disease in Brazil from 1979 to 2009: trends and regional differences. | Q50111267 | ||
| Trypanosoma cruzi infection induces a massive extrafollicular and follicular splenic B-cell response which is a high source of non-parasite-specific antibodies. | Q50559773 | ||
| Expression of trypomastigote trans-sialidase in metacyclic forms of Trypanosoma cruzi increases parasite escape from its parasitophorous vacuole. | Q51806092 | ||
| Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. | Q51822633 | ||
| Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases. | Q52250588 | ||
| Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. | Q52445292 | ||
| Studies in search of a suitable experimental insect model for xenodiagnosis of hosts with Chagas' disease. 4--The reflection of parasite stock in the responsiveness of different vector species to chronic infection with different Trypanosoma cruzi st | Q52449377 | ||
| Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi. | Q53368984 | ||
| Impaired production of proinflammatory cytokines and host resistance to acute infection with Trypanosoma cruzi in mice lacking functional myeloid differentiation factor 88. | Q53905520 | ||
| Mechanisms of TLR9 activation. | Q54494727 | ||
| A functional network of intramolecular cross-reacting epitopes delays the elicitation of neutralizing antibodies to Trypanosoma cruzi trans-sialidase. | Q54541568 | ||
| The evolution of Trypanosoma cruzi: the 'bat seeding' hypothesis | Q56927701 | ||
| Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response | Q57067411 | ||
| Hexadecylpalmitoyglycerol or ceramide is linked to similar glycophosphoinositol anchor-like structures in Trypanosoma cruzi | Q57067563 | ||
| Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism | Q57080133 | ||
| Most B Cells in Acute Trypanosoma cruzi Infection Lack Parasite Specificity | Q57842433 | ||
| Trypomastigotes and amastigotes of Trypanosoma cruzi induce apoptosis and STAT3 activation in cardiomyocytes in vitro | Q58843283 | ||
| PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease | Q58843303 | ||
| Cutting edge: nucleotide-binding oligomerization domain 1-dependent responses account for murine resistance against Trypanosoma cruzi infection | Q58844182 | ||
| Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy | Q58844325 | ||
| Immunodominance: a new hypothesis to explain parasite escape and host/parasite equilibrium leading to the chronic phase of Chagas' disease? | Q58844446 | ||
| Trypanosoma cruzi: predominance of IgG2a in nonspecific humoral response during experimental Chagas' disease | Q58844647 | ||
| Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection | Q58845195 | ||
| Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi | Q58845221 | ||
| Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi | Q58848531 | ||
| The trans-sialidase of Trypanosoma cruzi is anchored by two different lipids | Q58855157 | ||
| gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway | Q70064606 | ||
| The mechanisms of Trypanosoma cruzi invasion of mammalian cells | Q70899913 | ||
| Structural variation in the glycoinositolphospholipids of different strains of Trypanosoma cruzi | Q71939521 | ||
| Tc45, a dimorphic Trypanosoma cruzi immunogen with variable chromosomal localization, is calreticulin | Q74076573 | ||
| Proapoptotic activity of a Trypanosoma cruzi ceramide-containing glycolipid turned on in host macrophages by IFN-gamma | Q77484030 | ||
| Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes induce in vivo leukocyte recruitment dependent on MCP-1 production by IFN-gamma-primed-macrophages | Q78058095 | ||
| Purification and biochemical characterization of four iron superoxide dismutases in Trypanosoma cruzi | Q81556847 | ||
| Macrophage complement receptors and pathogen clearance | Q36859212 | ||
| Immune system recognition of Trypanosoma cruzi | Q36891278 | ||
| Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine | Q36922758 | ||
| Trypanosoma cruzi antioxidant enzymes as virulence factors in Chagas disease | Q37086096 | ||
| Peroxynitrite, a stealthy biological oxidant | Q37168344 | ||
| CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance | Q37200211 | ||
| Unleashing the therapeutic potential of NOD-like receptors | Q37502679 | ||
| Glycobiology of Trypanosoma cruzi | Q37510071 | ||
| Enzymes of the antioxidant network as novel determiners of Trypanosoma cruzi virulence | Q37540773 | ||
| Fighting the oxidative assault: the Trypanosoma cruzi journey to infection | Q37555693 | ||
| Antigenic variation in Giardia lamblia | Q37587368 | ||
| The effects of nitric oxide on the immune system during Trypanosoma cruzi infection | Q37597063 | ||
| The role of parasite persistence in pathogenesis of Chagas heart disease | Q37613774 | ||
| Molecular mechanisms of host cell invasion by Trypanosoma cruzi | Q37769831 | ||
| Insights into the role of Toll-like receptors in modulation of T cell responses | Q37777344 | ||
| The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease | Q37788829 | ||
| Molecular mechanisms underlying the control of antigenic variation in African trypanosomes | Q37795350 | ||
| Regulation of antigenic variation in Giardia lamblia | Q37899177 | ||
| Vesicles as carriers of virulence factors in parasitic protozoan diseases | Q38034618 | ||
| Virulence factors of Trypanosoma cruzi: who is who? | Q38046031 | ||
| Mechanisms of complement lectin pathway activation and resistance by trypanosomatid parasites | Q38051898 | ||
| Silence, activate, poise and switch! Mechanisms of antigenic variation in Plasmodium falciparum. | Q38076799 | ||
| Microvesicles and intercellular communication in the context of parasitism. | Q38137085 | ||
| Gene expression changes induced by Trypanosoma cruzi shed microvesicles in mammalian host cells: relevance of tRNA-derived halves. | Q38987100 | ||
| Isolation of Trypanosoma cruzi DNA in 4,000-year-old mummified human tissue from northern Chile. | Q39035804 | ||
| Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: Light microscopy and immunohistochemical findings | Q39067405 | ||
| Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection | Q39200565 | ||
| ??? | Q58648633 | ||
| Control of VSG gene expression sites | Q34253288 | ||
| A trypanosome-soluble factor induces IP3 formation, intracellular Ca2+ mobilization and microfilament rearrangement in host cells | Q34312703 | ||
| Glycoinositolphospholipids, free and as anchors of proteins, in Trypanosoma cruzi | Q34319207 | ||
| The MASP family of Trypanosoma cruzi: changes in gene expression and antigenic profile during the acute phase of experimental infection | Q34385087 | ||
| Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. | Q34394414 | ||
| Antigenic variation and allelic exclusion | Q34602633 | ||
| Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity | Q34675951 | ||
| Circulating microparticles: square the circle | Q34680832 | ||
| Antigenic variation in Giardia lamblia is regulated by RNA interference | Q34902943 | ||
| Mechanisms of cellular iron acquisition: another iron in the fire | Q35015885 | ||
| Requirement of UNC93B1 reveals a critical role for TLR7 in host resistance to primary infection with Trypanosoma cruzi | Q35147723 | ||
| Exosomes: secreted vesicles and intercellular communications | Q35161550 | ||
| NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease | Q35230292 | ||
| Formation and remodeling of inositolphosphoceramide during differentiation of Trypanosoma cruzi from trypomastigote to amastigote | Q35612945 | ||
| Glycoinositolphospholipid from Trypanosoma cruzi: structure, biosynthesis and immunobiology. | Q35622904 | ||
| Characterization of an immunodominant antigenic epitope from Trypanosoma cruzi as a biomarker of chronic Chagas' disease pathology. | Q35739066 | ||
| The Immune Response to Trypanosoma cruzi: Role of Toll-Like Receptors and Perspectives for Vaccine Development | Q35838023 | ||
| Antigenic variation in Trypanosoma brucei: facts, challenges and mysteries | Q35853298 | ||
| Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. | Q35884180 | ||
| Oxidative stress fuels Trypanosoma cruzi infection in mice | Q36068270 | ||
| Multigene families in Trypanosoma cruzi and their role in infectivity | Q36156052 | ||
| Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm. | Q36231609 | ||
| Host cell invasion by trypanosomes requires lysosomes and microtubule/kinesin-mediated transport | Q36237039 | ||
| New approaches in vaccine development for parasitic infections | Q36253622 | ||
| The Trypanosoma cruzi-host-cell interplay: location, invasion, retention | Q36263007 | ||
| North American import? Charting the origins of an enigmatic Trypanosoma cruzi domestic genotype. | Q36348152 | ||
| Role in host cell invasion of Trypanosoma cruzi-induced cytosolic-free Ca2+ transients | Q36362903 | ||
| Lysosomal fusion is essential for the retention of Trypanosoma cruzi inside host cells. | Q36399371 | ||
| Trypanosoma cruzi surface mucins: host-dependent coat diversity | Q36401388 | ||
| Sequence diversity of the Trypanosoma cruzi complement regulatory protein family | Q36421495 | ||
| Breaking the waves: improved detection of copy number variation from microarray-based comparative genomic hybridization. | Q36465662 | ||
| Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism. | Q36655907 | ||
| Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite | Q36740177 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Trypanosoma cruzi | Q150162 |
| P304 | page(s) | 659 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Evasion of the Immune Response by Trypanosoma cruzi during Acute Infection | |
| P478 | volume | 6 |
| Q39003990 | Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need |
| Q58799039 | Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy? |
| Q39010376 | Biological factors that impinge on Chagas disease drug development |
| Q55364024 | CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease. |
| Q40110314 | Chagas disease: modulation of the inflammatory response by acetylcholinesterase in hematological cells and brain tissue. |
| Q91975356 | Circulating T Follicular Helper Cell Abnormalities Associated to Different Clinical Forms of Chronic Chagas Disease |
| Q99711499 | Comparative Analysis of the Secretome and Interactome of Trypanosoma cruzi and Trypanosoma rangeli Reveals Species Specific Immune Response Modulating Proteins |
| Q52364415 | Complement system contributes to modulate the infectivity of susceptible TcI strains of Trypanosoma cruzi. |
| Q93064937 | Cytosolic Fe-superoxide dismutase safeguards Trypanosoma cruzi from macrophage-derived superoxide radical |
| Q26740647 | Dendritic Cells: A Double-Edged Sword in Immune Responses during Chagas Disease |
| Q60047543 | Disease Tolerance and Pathogen Resistance Genes May Underlie Persistence and Differential Progression to Chagas Disease Cardiomyopathy |
| Q37256759 | Doxycycline and Benznidazole Reduce the Profile of Th1, Th2, and Th17 Chemokines and Chemokine Receptors in Cardiac Tissue from Chronic Trypanosoma cruzi-Infected Dogs |
| Q95933435 | Effect of the Tc13Tul antigen from Trypanosoma cruzi on splenocytes from naïve mice |
| Q89419160 | Evaluation of the immune response against Trypanosoma cruzi cytosolic tryparedoxin peroxidase in human natural infection |
| Q52660744 | Experimental Chagas disease-induced perturbations of the fecal microbiome and metabolome. |
| Q53683164 | Extracellular Vesicles Shed By Trypanosoma cruzi Potentiate Infection and Elicit Lipid Body Formation and PGE2 Production in Murine Macrophages. |
| Q55220925 | Extracellular Vesicles in Chagas Disease: A New Passenger for an Old Disease. |
| Q47138016 | Galectin-3: A Friend but Not a Foe during Trypanosoma cruzi Experimental Infection. |
| Q40429340 | Gene Expression Profiling and Functional Characterization of Macrophages in Response to Circulatory Microparticles Produced during Trypanosoma cruzi Infection and Chagas Disease. |
| Q40293929 | Immune complexes in chronic Chagas disease patients are formed by exovesicles from Trypanosoma cruzi carrying the conserved MASP N-terminal region |
| Q39325453 | Implication of Apoptosis for the Pathogenesis of Trypanosoma cruzi Infection |
| Q51148229 | Integrative Approaches to Understand the Mastery in Manipulation of Host Cytokine Networks by Protozoan Parasites with Emphasis on Plasmodium and Leishmania Species. |
| Q55188236 | Lipids From Trypanosoma cruzi Amastigotes of RA and K98 Strains Generate a Pro-inflammatory Response via TLR2/6. |
| Q58730645 | Molecular and cellular characterization of apoptosis in flat oyster a key mechanisms at the heart of host-parasite interactions |
| Q47381302 | Protective effect of aspirin treatment on mouse behavior in the acute phase of experimental infection with Trypanosoma cruzi. |
| Q37592659 | Protozoan Parasites and Type I IFNs |
| Q58865487 | Relevance of Trypanothione Reductase Inhibitors on Trypanosoma cruzi Infection: A Systematic Review, Meta-Analysis, and In Silico Integrated Approach |
| Q98465708 | The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence |
| Q58705710 | The Unsolved Jigsaw Puzzle of the Immune Response in Chagas Disease |
| Q41619655 | Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin |
| Q60932659 | Upregulation of Cardiac IL-10 and Downregulation of IFN- in Balb/c IL-4 in Acute Chagasic Myocarditis due to Colombian Strain of Trypanosoma cruzi |
Search more.